Recent Progress in Rational Drug Design of Neuraminidase Inhibitors

E-ISSN： 1875-533x|14|27|2872-2891

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.27, 2007-11, pp. : 2872-2891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent progress and challenges in the discovery of new neuraminidase inhibitors

By Chamni Supakarn De-Eknamkul Wanchai

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 409-423

Informa Healthcare

Access to resources Recommend Favorite

Progress in the Rational Design for Polypharmacology Drug

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3182-3189

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Design of Selectin Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 7, 2003-11 ,pp. : 679-687

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Structure-Based Design of Neuraminidase Inhibitors as Antiinfluenza Agents

Current Medicinal Chemistry, Vol. 19, Iss. 34, 2012-12 ,pp. : 5885-5894

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite